In Hippocampus, Protein's Malfunction Is Potential Link to Memory and Other Impairments Seen in Schizophrenia
Researchers have made an intriguing discovery about how a defective protein may be implicated in a mechanism that greatly increases the risk of schizophrenia in certain individuals and may help… Read More
A Close Look at How COVID-19 Infection Can Damage the Brain
In a much-discussed report appearing online March 26 in the Journal of the American Medical Association (JAMA), three researchers have attempted to explain the potential causes of a wide range of… Read More
Drugs Targeting the Glutamate System Warrant Continued Development for Schizophrenia, Study Finds
In the continuing effort to develop new medicines to treat schizophrenia, a team led by BBRF Scientific Council member Jeffrey Lieberman, M.D., and including nine other Council Members, BBRF grantees… Read More
Research on Antioxidant Role in Schizophrenia and Psychosis Points to Possible Therapeutic Value of Compound Found in Broccoli
Researchers at Johns Hopkins University co-led by Akira Sawa, M.D., Ph.D., a BBRF Scientific Council member, and including seven other current and past BBRF grant recipients, have published a trio of… Read More